U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940777) titled 'A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)' on Oct. 29.
Brief Summary: A study to evaluate the safety and efficacy of Mavacamten in adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)
Study Start Date: Dec. 29
Study Type: INTERVENTIONAL
Condition:
Non-obstructive Hypertrophic Cardiomyopathy
Intervention:
DRUG: Mavacamten
Specified dose on specified days
OTHER: Placebo
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital...